Interferon-beta1b in the treatment of secondary progressive MS: impact on quality of life.
about
A review of complementary and alternative medicine (CAM) by people with multiple sclerosisInterferon beta for secondary progressive multiple sclerosisInterferon-β-1b: a review of its use in multiple sclerosisProspect of brain-machine interface in motor disabilities: the future support for multiple sclerosis patient to improve quality of lifeUsing existing data to identify candidate items for a health state classification system in multiple sclerosis.Understanding unexpected courses of multiple sclerosis among patients using complementary and alternative medicine: A travel from recipient to explorer.Pilot trial of low-dose naltrexone and quality of life in multiple sclerosis.Quality of life in multiple sclerosis.Health-related quality of life in multiple sclerosis: current evidence, measurement and effects of disease severity and treatment.The use of quality of life measures in multiple sclerosis research.Influence of Interferon beta treatment on quality of life in multiple sclerosis patientsOne year changes in disability in multiple sclerosis: neurological examination compared with patient self reportQuality of life and impairment in patients with multiple sclerosis.A review about the impact of multiple sclerosis on health-related quality of life.Effect of drugs in secondary disease progression in patients with multiple sclerosis.Quality of life measures for the palliative care of people severely affected by multiple sclerosis: a systematic review.Do generic utility measures capture what is important to the quality of life of people with multiple sclerosis?Quality of life in multiple sclerosis: effects of current treatment options.Health-Related Quality of Life in Patients with Multiple Sclerosis: Impact of Disease-Modifying Drugs.A systematic approach to analyse health-related quality of life in multiple sclerosis: the GEDMA study.Quality of life and depression in multiple sclerosis patients: longitudinal results of the BetaPlus study.Evolution of Patient-Reported Outcomes and Their Role in Multiple Sclerosis Clinical Trials.Therapeutic effect of Avonex, Rebif and Betaferon on quality of life in multiple sclerosis.The effects of clinical interventions on health-related quality of life in multiple sclerosis: a meta-analysis.Factors that predict health-related quality of life in patients with relapsing-remitting multiple sclerosis.Health-related quality of life in secondary progressive multiple sclerosis.Change in clinician-assessed measures of multiple sclerosis and subject-reported quality of life: results from the IMPACT study.Change in quality of life in patients with relapsing-remitting multiple sclerosis over 2 years in relation to other clinical parameters: results from a trial of intramuscular interferon {beta}-1a.Long-term exercise improves functional impairment but not quality of life in multiple sclerosis.
P2860
Q22252861-E1D314D4-AE15-41C1-8D40-34FD35882196Q24203879-2CADC3B4-08B6-4D2F-AE74-335B3CECA3B3Q28299838-4224CB0C-F700-4B7C-9C88-852679493951Q28657453-ED061DA1-2354-4938-BAD8-C47424F51C84Q30715052-F6472440-3F1B-414F-8913-2BBF2FA60BA3Q33975288-9F41350B-9A5A-430A-92BB-EFF17D6513E4Q34023379-673DE14B-C022-4321-B14E-A4DB1ABED4CEQ34481312-EFA4D9E5-38AC-46CD-B604-23554152958DQ34826429-FB54CCAD-C08E-455B-900D-7B9787C24EB4Q35078168-1D200AE9-9EB5-4C1C-B722-BA5679B4C52FQ35250764-C7BBAB2B-DEA4-4309-905E-7CC0A367B2FCQ35472473-C597DCE5-DE05-4DAD-96D9-916037B75584Q35483656-9A31D73E-B9C5-496B-A713-F5C5FFEFDEE9Q35583727-2F3B17C9-E5D2-4991-8B12-4F0520045FD0Q35818152-3C9E57DD-AD8D-4BEA-BA83-11B5FC6647A6Q35976064-09A88A99-F192-4BA8-A5AA-DFCAFC08862AQ36831616-3EB3BD65-0E8B-46C7-9EAE-8C1E0B74B23AQ37710122-0E400AA2-86AC-47C4-9087-DE2FF150D0DFQ38728373-38FF940A-A024-48FF-8044-92D7E1F1613AQ47221401-44587399-853E-4317-BFA7-4A6E5FD2668FQ47864604-CAB9FBCF-9C90-4464-A0D2-3AF1B51EBA4FQ47947804-8697CFFF-E559-4461-B420-673A3F28362DQ48040099-736E7D03-AC9B-496F-B2CC-AB401E7AE617Q48337817-4F5937F8-D18C-4075-A7B5-5CCEBBD49EC7Q48374609-476A1E1C-1E2D-4060-9396-D393FF386BC8Q48471623-887A802A-265F-4128-9842-446216FB03B1Q51918814-8DF997E2-AD02-4D2E-8EAC-D3AB2660EFA7Q53051361-E5D2BA46-3BCA-477A-B6F3-3C42A10D2E9EQ53305144-1E01A283-E7CA-435D-B823-96F7D0FF8E04
P2860
Interferon-beta1b in the treatment of secondary progressive MS: impact on quality of life.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Interferon-beta1b in the treat ...... MS: impact on quality of life.
@en
Interferon-beta1b in the treat ...... MS: impact on quality of life.
@nl
type
label
Interferon-beta1b in the treat ...... MS: impact on quality of life.
@en
Interferon-beta1b in the treat ...... MS: impact on quality of life.
@nl
prefLabel
Interferon-beta1b in the treat ...... MS: impact on quality of life.
@en
Interferon-beta1b in the treat ...... MS: impact on quality of life.
@nl
P2093
P356
P1433
P1476
Interferon-beta1b in the treat ...... MS: impact on quality of life.
@en
P2093
A J Thompson
C Miltenburger
C Pozzilli
European Study Group on Interferon-beta1b in Secondary Progressive MS
J A Freeman
K Beckmann
R Fitzpatrick
P304
P356
10.1212/WNL.57.10.1870
P407
P577
2001-11-01T00:00:00Z